The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.

BMC Nephrol 2019 08 5;20(1):301. Epub 2019 Aug 5.

Department of Nephrology, Zhongshan Hospital, Fudan University, NO180, Feng'lin Road, Shanghai, 200032, China.

Background: Impaired T cell immune function exists in end-stage renal disease (ESRD) patients. Dialysis treatment may lead to changes in T cell subsets. In the present study, we aimed to identify alterations of T cell phenotypes in ESRD patients, especially in those receiving peritoneal dialysis (PD), and analyze the potential associated factors.

Methods: In the present study, 110 PD patients and 110 age/gender-matched hemodialysis (HD) patients who met the inclusion criteria were studied. Pre-dialysis blood samples were obtained and analyzed by flow cytometry to detect the expression of CD45RO and CCR7. Univariate and multivariate regression analyses were used to determine the factors associated with the alteration of T cell phenotypes.

Results: In all dialysis patients, age was associated with the frequencies of both CD4+ and CD8+ naïve T cells, effector memory (EM) T cells and effector memory RA (EMRA) T cells but not central memory (CM) T cells. Dialysis modality was also associated with T cell subsets. Compared with HD patients, PD patients showed an increase in both CD4+ and CD8+ CM T cells and a reduction in both CD4+ and CD8+ EM and EMRA T cells. However, the number of CD4+ naïve T cells was lower and the number of CD8+ naïve T cells was higher in PD patients than those in HD patients. In PD patients, further multivariate analysis revealed that the frequency of CD4+ naïve T cells was positively associated with nPCR, while the frequency of CD8+ naïve T cells was negatively associated with age.

Conclusion: In dialysis patients, the dialysis modality and age influence T cell subsets. There is a progression from naïve to effector T cells in HD patients compared with PD patients. In PD patients, different factors may influence the frequencies of CD4+ and CD8+ naïve T cells.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-019-1475-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683494PMC
August 2019

Publication Analysis

Top Keywords

naïve cells
24
cd4+ cd8+
16
cd8+ naïve
16
patients patients
16
patients
15
cells
12
patients dialysis
12
cell subsets
12
dialysis modality
12
emra cells
8
memory cells
8
cells effector
8
frequencies cd4+
8
cd4+ naïve
8
compared patients
8
dialysis patients
8
esrd patients
8
effector memory
8
renal disease
8
cell phenotypes
8

Similar Publications

Naïve and central memory T-cell lymphopenia in end-stage renal disease.

Kidney Int 2006 Jul 31;70(2):371-6. Epub 2006 May 31.

Division of Nephrology and Hypertension, Hallym University, Chunchon, Korea.

End-stage renal disease (ESRD) is associated with increased propensity to infections, diminished response to vaccination, impaired cell-mediated immunity, and reduced CD4+/CD8+ T-lymphocyte ratio. Four subsets of CD4+ and CD8+ T cells have been recently identified: naïve cells (as yet uncommitted), central memory (CM) cells (previously programmed), and CD45RA-positive and CD45RA-negative effector memory (EM) cells (programmed to perform specific effector functions). The effect of ESRD on subpopulations of T lymphocytes is unclear and was studied here. Read More

View Article and Full-Text PDF
July 2006

Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients.

Immunol Lett 2012 Jan 8;141(2):181-9. Epub 2011 Oct 8.

Conversant Research Consorcium in Immunologic Disease, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Patients with end-stage renal disease (ESRD) exhibit immune dysregulation, but the precise immunological profile and the effect of hemodialysis (HD) on it has not been investigated fully. Thirty-eight ESRD patients (22 on HD and 16 in pre-dialysis) and 24 healthy volunteers were included. We compared the T cell immune profiles as in these patients. Read More

View Article and Full-Text PDF
January 2012

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.

Clin Exp Immunol 2009 Jul;157(1):90-7

Department of Immunology, Imperial College London, Chelsea & Westminster Hospital, London, UK.

Human immunodeficiency virus (HIV)-1 causes T cell anergy and affects T cell maturation. Various mechanisms are responsible for impaired anti-HIV-1-specific responses: programmed death (PD)-1 molecule and its ligand PD-L1 are negative regulators of T cell activity and their expression is increased during HIV-1 infection. This study examines correlations between T cell maturation, expression of PD-1 and PD-L1, and the effects of their blockade. Read More

View Article and Full-Text PDF
July 2009

Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes.

Clin Immunol 2006 Jan 27;118(1):83-91. Epub 2005 Oct 27.

Department of Internal Medicine, Division of Nephrology, Room Ee 551, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

We hypothesized that progressive loss of renal function specifically affects certain T cell subsets. T lymphocyte subsets of patients with chronic kidney disease and healthy controls were characterized by flow cytometry using heparin-anticoagulated whole blood samples. Plasma interleukin (IL)-7 and IL-15 concentrations were determined as these cytokines are critically involved in T cell homeostasis. Read More

View Article and Full-Text PDF
January 2006